The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Kane Biotech Inc Hits New 50-day High

Kane Biotech Inc closed up sharply Wednesday, rallying $0.02 or 15.38% to $0.15 and setting a new 50-day high. Over the last five days, shares have gained 20.00% and 20.00% year to date. Shares have outperformed the S&P TSX by 15.73% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.06
Updated July 26 3:45 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-684.98%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense0111
Selling / general / administrative1001
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-1000
Operating income00-1-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax0-1-1-1
Income after tax0-1-1-1
Income tax, total--------
Net income0-1-1-1
Total adjustments to net income--------
Net income before extra. items0-1-1-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-1-1-1
Inc. avail. to common incl. extra. items0-1-1-1
Diluted net income0-1-1-1
Dilution adjustment--------
Diluted weighted average shares46463530
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.01-0.02-0.03
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.01-0.01-0.02-0.03